Delivery Order SPE2DB22D1103-SPE2DB25FTCQ4

Award Date 12/6/24
Potential Completion Date 12/9/24
Potential Value $3.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB25FTCQ4
    Delivery Order

This federal contract award, with an ID of SPE2DB22D1103|SPE2DB25FTCQ4, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566635736 ! TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a pharmaceutical product.

The contract has a ceiling value of $3,539.00 and is a Delivery Order under a Firm Fixed Price contract type. It does not have a set-aside designation, indicating open competition. The contract has an ultimate completion date of December 9, 2024.

AmerisourceBergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) and maintains a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 3/7/25, 9:58 AM